<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John W Baddley, MD, MSPH</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 17, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Histoplasmosis is the most common endemic mycosis in patients with acquired immunodeficiency syndrome (AIDS) [<a href="#rid1">1-3</a>]. Although the risk of disease in patients with human immunodeficiency virus (HIV) has declined with effective antiretroviral therapy [<a href="#rid4">4,5</a>], it continues to cause severe morbidity and mortality in endemic areas, particularly in resource-limited settings [<a href="#rid6">6</a>]. </p><p>The epidemiology, clinical manifestations, and diagnosis of histoplasmosis in patients with HIV will be reviewed here. The treatment of histoplasmosis in patients with HIV, as well as topic reviews that discuss histoplasmosis in patients without HIV, are found elsewhere. (See  <a class="medical medical_review" href="/d/html/6996.html" rel="external">"Treatment of histoplasmosis in patients with HIV"</a> and  <a class="medical medical_review" href="/d/html/2451.html" rel="external">"Diagnosis and treatment of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV"</a> and  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis"</a> and  <a class="medical medical_review" href="/d/html/2455.html" rel="external">"Pathogenesis and clinical manifestations of disseminated histoplasmosis"</a>.) </p><p class="headingAnchor" id="H2"><span class="h1">EPIDEMIOLOGY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Geographic distribution</strong> − Histoplasmosis is found in temperate zones worldwide; specific endemic areas include the Mississippi and Ohio river valleys, the Caribbean, southern Mexico, certain parts of Central and South America, Africa, and Asia. In these regions, the fungus is found in high concentrations in soil contaminated with bird or bat excreta [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis", section on 'Reservoir'</a> and  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sources of infection</strong> − Transmission occurs via inhalation of <em>Histoplasma capsulatum </em>conidia<em> </em>from the soil. Thus, infection may be acquired through a multitude of activities (eg, demolition and construction, cleaning out old structures or chicken coops, spelunking, and gardening or handling of plants), which can lead to inhalation of the pathogen through contaminated soil [<a href="#rid8">8-10</a>]. Most primary cases of infection occur shortly after initial exposure; disseminated infection has also been described in patients living outside of endemic areas, suggesting endogenous reactivation of latent foci of infection that were acquired from previous travel or residence in endemic areas [<a href="#rid8">8,11-13</a>]. (See  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis", section on 'Epidemiology'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Burden of disease</strong> − Early in the HIV epidemic, histoplasmosis occurred in 5 to 27 percent of patients with advanced HIV living in endemic areas of the United States [<a href="#rid8">8</a>]. Despite the risk of disease declining with effective antiretroviral therapy (ART) [<a href="#rid4">4,5</a>], histoplasmosis remains one of the most common infections among persons with HIV living in Latin America. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Risk factors</strong> − The major risk factor for developing histoplasmosis in persons with HIV is a CD4 count ≤150 cells/microL among untreated individuals. Other risk factors include occupations and activities associated with exposure to soil that contains bird or bat droppings [<a href="#rid4">4</a>]. ART is protective against histoplasmosis. </p><p></p><p class="bulletIndent1">The importance of cellular immunity was demonstrated in one study of T-cell proliferative responses to <em>Histoplasma</em> antigens; in vitro data showed that T-cell proliferative responses were depressed in persons with HIV who had a history of histoplasmosis and CD4 counts ranging from 200 to 500 cells/microL compared with persons without HIV [<a href="#rid14">14</a>]. </p><p></p><p class="headingAnchor" id="H4"><span class="h1">MICROBIOLOGY AND PATHOGENESIS</span><span class="headingEndMark"> — </span>There are two varieties of <em>H. capsulatum</em> that infect humans: <em>H. capsulatum var. capsulatum </em>and<em> H. capsulatum var. duboisii</em>. The most common variety, <em>H. capsulatum var. capsulatum,</em> is found worldwide while <em>H. capsulatum var. duboisii</em> only exists in Africa [<a href="#rid15">15</a>]. </p><p>This endemic fungus is thermally dimorphic; it exists as mold in the environment and as yeast at body temperature. Microscopically, <em>H. capsulatum</em> has hyaline, septate hyphae, with spherical, thick-walled tuberculate conidia and smaller microconidia  (<a class="graphic graphic_picture graphicRef68444" href="/d/graphic/68444.html" rel="external">picture 1</a>). In tissues, the organism appears as 2 to 4 micrometer oval, budding yeasts that can be found both inside and outside macrophages. </p><p>Infection with <em>H. capsulatum</em> occurs when the mold form is inhaled from contaminated soil or other material into the lungs. There, <em>H. capsulatum </em>converts into its yeast form and is ingested by macrophages. Macrophages then proceed to hematogenously spread the organism through the reticuloendothelial system (liver, spleen, lymph nodes, and bone marrow). CD4 cells play an important role in controlling primary infection [<a href="#rid15">15</a>]. When T cell immunity is impaired, the macrophages are not activated to kill the organisms, resulting in a suboptimal immune response and disseminated infection. Additional information on the pathogenesis of pulmonary and disseminated histoplasmosis is discussed elsewhere. (See  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis", section on 'Pathogenesis'</a> and  <a class="medical medical_review" href="/d/html/2455.html" rel="external">"Pathogenesis and clinical manifestations of disseminated histoplasmosis", section on 'Pathogenesis'</a>.)</p><p class="headingAnchor" id="H5"><span class="h1">CLINICAL PRESENTATION</span></p><p class="headingAnchor" id="H1532838780"><span class="h2">Spectrum and time course of disease</span><span class="headingEndMark"> — </span>Histoplasmosis can range from asymptomatic infection to life-threatening disseminated disease. In the immunocompetent host and in patients with HIV and CD4 counts &gt;150 cells/microL, histoplasmosis usually presents as a mild self-limiting pulmonary illness [<a href="#rid3">3,16</a>] (see  <a class="medical medical_review" href="/d/html/2450.html" rel="external">"Pathogenesis and clinical features of pulmonary histoplasmosis", section on 'Clinical manifestations'</a>). Patients with HIV and CD4 counts ≤150 cells/microL usually develop acute disseminated histoplasmosis, characterized by fevers and weight loss [<a href="#rid15">15</a>]. Isolated pulmonary involvement without dissemination in patients with advanced HIV is rare, occurring in less than 5 percent of cases [<a href="#rid2">2,8</a>]. </p><p>Histoplasmosis-associated immune reconstitution inflammatory syndrome is uncommon, but unusual manifestations such as splenic infarction and ulcerative skin lesions have been reported in patients who had recently started antiretroviral therapy (ART) [<a href="#rid17">17</a>]. (See <a class="local">'Immune reconstitution inflammatory syndrome'</a> below.)</p><p>Incubation period ranges from one to three weeks, although some infections in patients with advanced HIV are due to reactivation of a latent infection. </p><p class="headingAnchor" id="H2539229158"><span class="h2">Clinical signs and symptoms</span><span class="headingEndMark"> — </span>Most patients with advanced HIV will present with acute disseminated histoplasmosis. Common extrapulmonary sites of involvement include liver, spleen, gastrointestinal tract, bone marrow, adrenal glands, skin, and the central nervous system (CNS). With the exception of bone marrow, osseous involvement is rare with <em>H. capsulatum var. capsulatum </em>but was frequently<em> </em>observed with<em> var. duboisii </em>infections<em> </em>[<a href="#rid18">18</a>]<em>.</em></p><p>Clinical symptoms and signs are varied and depend on the organs affected. Common symptoms include fever, night sweats, fatigue, weight loss, nausea, vomiting, cough, and dyspnea [<a href="#rid3">3,8,16,19-23</a>]. Diarrhea and headache are less common. Presence of headache should prompt suspicion for meningitis. Further details on the clinical presentation of histoplasmosis within each organ are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/d/html/2455.html" rel="external">"Pathogenesis and clinical manifestations of disseminated histoplasmosis", section on 'Clinical manifestations'</a>.)</p><p>Physical examination often demonstrates hepatosplenomegaly and lymphadenopathy. Skin and mucosal lesions can occur  (<a class="graphic graphic_picture graphicRef78902" href="/d/graphic/78902.html" rel="external">picture 2</a>) and are indicative of disseminated disease. Cutaneous lesions may be more common in Brazil than in the United States [<a href="#rid6">6,24</a>] and in <em>H. capsulatum var. duboisii </em>infections [<a href="#rid18">18</a>]; these variant clinical manifestations may be related to genetic differences in the causative organisms from the respective geographic locations [<a href="#rid24">24</a>].</p><p>Patients with advanced HIV can also present with severe, life-threatening infection characterized by shock, acute respiratory distress, hepatic and renal failure, altered mental status, disseminated intravascular coagulation, and reactive hemophagocytic syndrome [<a href="#rid8">8,19,20,22</a>]. Mortality can be as high as 50 percent in patients with advanced HIV, despite appropriate therapy [<a href="#rid21">21,25</a>]. Such life-threatening infections tend to occur in patients who are not on ART and are less commonly seen with the widespread use of ART.</p><p class="headingAnchor" id="H6"><span class="h2">Laboratory abnormalities</span><span class="headingEndMark"> — </span>Laboratory abnormalities can vary depending on which organs are involved but generally include pancytopenia secondary to bone marrow involvement [<a href="#rid16">16</a>] and elevated alkaline phosphatase; aminotransferases are often only mildly elevated. Hyperkalemia and hyponatremia are suggestive of adrenal involvement. Elevated creatinine can be seen in patients with acute kidney injury and is a poor prognostic sign [<a href="#rid1">1,3,16</a>]. Nonspecific markers of inflammation, such as lactate dehydrogenase, ferritin, erythrocyte sedimentation rate, and C-reactive protein are often elevated [<a href="#rid6">6</a>]. </p><p>If meningitis is present, cerebrospinal fluid (CSF) findings are often similar to patterns seen in other fungal etiologies (eg, 50 to 500 predominantly mononuclear white cells, low glucose level, and mildly elevated protein level). CSF findings may be altered in patients presenting with isolated focal CNS lesions or vascular CNS abnormalities. (See  <a class="medical medical_review" href="/d/html/2455.html" rel="external">"Pathogenesis and clinical manifestations of disseminated histoplasmosis", section on 'Central nervous system disease'</a>.) </p><p class="headingAnchor" id="H7"><span class="h2">Radiographic manifestations</span><span class="headingEndMark"> — </span>As with clinical signs and symptoms and laboratory abnormalities, radiographic manifestations vary based on which organ systems are involved. Pulmonary infiltrates are seen in 40 to 50 percent of patients with advanced HIV and disseminated histoplasmosis and are commonly characterized by diffuse interstitial or reticulonodular infiltrates  (<a class="graphic graphic_diagnosticimage graphicRef79439" href="/d/graphic/79439.html" rel="external">image 1</a>) [<a href="#rid11">11</a>]. Focal infiltrates, which are common in acute pulmonary histoplasmosis, are rare in disseminated histoplasmosis. Other less common findings include pleural effusions, mediastinal adenopathy, cavitary disease, and calcified granulomas [<a href="#rid8">8,19</a>]. In one case series, chest radiographic abnormalities were reported in 50 to 70 percent of patients with advanced HIV and disseminated infection [<a href="#rid19">19</a>]. Occasionally, the initial radiograph may be normal. </p><p>Computed tomography imaging of the abdomen may demonstrate hepatosplenomegaly and enlarged adrenals with necrosis in the central area. </p><p class="headingAnchor" id="H2778198731"><span class="h2">Immune reconstitution inflammatory syndrome</span><span class="headingEndMark"> — </span>Immune reconstitution inflammatory syndrome (IRIS) associated with histoplasmosis is very rare. As an example, in one retrospective study of 22 patients with histoplasmosis-associated IRIS, the incidence was 0.74 cases per 1000 person-years, median CD4 cell count at the time of ART initiation was 54 cells/microL, and median time to IRIS symptoms onset after ART initiation was 11 days [<a href="#rid26">26</a>]. Fever, diarrhea, and lymphadenopathy were the most common presenting signs and symptoms of IRIS associated with histoplasmosis. (See  <a class="medical medical_review" href="/d/html/3762.html" rel="external">"Immune reconstitution inflammatory syndrome"</a>.)</p><p class="headingAnchor" id="H506106047"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of disseminated histoplasmosis varies depending on the organ systems involved but generally includes both infectious and noninfectious entities that present with a similar constellation of clinical signs and symptoms (eg, fever, weight loss, hepatosplenomegaly, lymphadenopathy, and pancytopenia). </p><p class="bulletIndent1"><span class="glyph">●</span><strong>Tuberculosis</strong> − Tuberculosis is the leading infection to consider in the differential diagnosis of histoplasmosis. Often tuberculosis infection and histoplasmosis can coexist in the same patient and is commonly reported in Latin America [<a href="#rid25">25,27,28</a>]. Therefore, diagnostic evaluation for both infections is indicated. Histoplasmosis and tuberculosis can be very difficult to distinguish based on clinical presentation and laboratory/imaging data alone and almost always require culture or histopathology data for diagnosis. (See  <a class="medical medical_review" href="/d/html/8024.html" rel="external">"Clinical manifestations, diagnosis, and treatment of miliary tuberculosis", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/111683.html" rel="external">"Diagnosis of pulmonary tuberculosis in adults", section on 'Patients with HIV infection'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other endemic fungi</strong> – Other endemic fungi, such as blastomycosis, coccidioidomycosis, paracoccidioidomycosis, and talaromycosis, can also present as a disseminated infection in a patient with advanced HIV infection who lives or has traveled to an area endemic for these other fungi. The endemic fungi can be difficult to differentiate from each other. Skin lesions are most common with blastomycosis or talaromycosis while mucous membrane lesions are more frequently seen in histoplasmosis and paracoccidioidomycosis. Histoplasmosis, paracoccidioidomycosis, and talaromycosis involve the reticuloendothelial system, resulting in hepatosplenomegaly and pancytopenia, signs that are uncommon in blastomycosis and coccidioidomycosis. (See  <a class="medical medical_review" href="/d/html/2437.html" rel="external">"Clinical manifestations and diagnosis of blastomycosis", section on 'Immunocompromised hosts'</a> and  <a class="medical medical_review" href="/d/html/2438.html" rel="external">"Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis", section on 'Immunocompromised hosts'</a> and  <a class="medical medical_review" href="/d/html/3035.html" rel="external">"Diagnosis and treatment of Talaromyces (Penicillium) marneffei infection", section on 'Diagnosis'</a> and  <a class="medical medical_review" href="/d/html/2460.html" rel="external">"Primary pulmonary coccidioidal infection", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/d/html/2449.html" rel="external">"Manifestations and treatment of nonmeningeal extrathoracic coccidioidomycosis", section on 'Clinical manifestations'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Disseminated cryptococcosis</strong> – Disseminated cryptococcosis can present similarly to disseminated histoplasmosis, with skin lesions, hepatomegaly, lymphadenopathy, and adrenal disease. Serum cryptococcal antigen is usually positive in patients with advanced HIV and disseminated cryptococcosis. (See  <a class="medical medical_review" href="/d/html/2421.html" rel="external">"Cryptococcus neoformans infection outside the central nervous system", section on 'Diagnosis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Multicentric Castleman disease</strong> – Multicentric Castleman disease (MCD) presents with multicentric lymphadenopathy, cytopenias, fevers, weight loss, and occasionally organ failure due to the hyperinflammatory response. Hypergammaglobulinemia is common in MCD while absent in histoplasmosis. MCD is typically diagnosed by histopathology. (See  <a class="medical medical_review" href="/d/html/4707.html" rel="external">"HHV-8/KSHV-associated multicentric Castleman disease", section on 'Diagnostic evaluation'</a> and  <a class="medical medical_review" href="/d/html/117312.html" rel="external">"HHV-8-negative/idiopathic multicentric Castleman disease", section on 'Evaluation'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sarcoidosis</strong> – Sarcoidosis can present very similarly to histoplasmosis, with fevers, weight loss, fatigue, lymphadenopathy, transaminitis, diffuse pulmonary infiltrates, and hepatomegaly. Splenomegaly and pancytopenia are uncommon. In general, infectious causes (including histoplasmosis) should be excluded prior to making the diagnosis of sarcoidosis. (See  <a class="medical medical_review" href="/d/html/4353.html" rel="external">"Clinical manifestations and diagnosis of sarcoidosis", section on 'Testing for tuberculosis and other infections'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malignancy</strong> – Hematologic malignancies (eg, lymphomas) can often present similarly to histoplasmosis, with fevers, weight loss, pancytopenias, and lymphadenopathy. Kaposi sarcoma can occasionally manifest with gastrointestinal symptoms or respiratory symptoms that may mimic the symptoms of histoplasmosis. (See  <a class="medical medical_review" href="/d/html/8033.html" rel="external">"AIDS-related Kaposi sarcoma: Clinical manifestations and diagnosis"</a>.)</p><p></p><p class="headingAnchor" id="H2914496285"><span class="h1">DIAGNOSTIC EVALUATION</span></p><p class="headingAnchor" id="H2335177557"><span class="h2">When to suspect histoplasmosis</span><span class="headingEndMark"> — </span>Timely diagnosis of histoplasmosis warrants a high index of clinical suspicion. Disseminated histoplasmosis should be suspected in patients with HIV and a current CD4 count ≤150 cells/microL who lived or are living in a histoplasmosis-endemic area and present with clinical manifestations consistent with disseminated histoplasmosis, such as: </p><p class="bulletIndent1"><span class="glyph">●</span>Fevers and weight loss</p><p class="bulletIndent1"><span class="glyph">●</span>Cough and/or dyspnea</p><p class="bulletIndent1"><span class="glyph">●</span>Skin and/or mucosal membrane lesions</p><p class="bulletIndent1"><span class="glyph">●</span>Nausea, vomiting, and abdominal pain</p><p class="bulletIndent1"><span class="glyph">●</span>Hepatosplenomegaly and/or lymphadenopathy</p><p class="bulletIndent1"><span class="glyph">●</span>Pancytopenia</p><p class="bulletIndent1"><span class="glyph">●</span>Other symptoms depending on organ system involved </p><p></p><p class="headingAnchor" id="H4105275951"><span class="h2">Approach to diagnosis</span><span class="headingEndMark"> — </span>Diagnostic testing should not be delayed if histoplasmosis is suspected. For patients in whom disseminated histoplasmosis is suspected, we suggest sending serum and urine<em> Histoplasma</em> antigen and fungal blood cultures using the lysis-centrifugation technique. Examination of tissues or body fluids for fungi using special stains (eg, Giemsa stain for bone marrow aspirates, methenamine silver stain for tissue specimens  (<a class="graphic graphic_picture graphicRef65482" href="/d/graphic/65482.html" rel="external">picture 3C</a>)) and culture of any available tissue or fluid specimens (eg, bone marrow aspirate, lymph node aspirate, skin biopsy tissue) should be performed  (<a class="graphic graphic_picture graphicRef68444" href="/d/graphic/68444.html" rel="external">picture 1</a>).<strong> </strong></p><p>Identification of <em>H. capsulatum</em> by staining or culture confirms the diagnosis. A positive antigen test strongly supports the diagnosis, according to the European Organisation for Research and Treatment of Cancer/Mycoses Study Group Education and Research Consortium diagnostic guidelines [<a href="#rid29">29</a>]. However, false positives can occur due to cross-reactivity with other endemic fungi (eg, blastomycosis, coccidioidomycosis, paracoccidioidomycosis). These tests are discussed in more detail below. Discussion of diagnostic evaluation of central nervous system (CNS) histoplasmosis is found elsewhere. (See  <a class="medical medical_review" href="/d/html/2461.html" rel="external">"Diagnosis and treatment of disseminated histoplasmosis in patients without HIV", section on 'Special considerations for diagnosing meningitis'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Antigen testing</strong> − We send urine and serum <em>Histoplasma</em> antigen as part of the initial diagnostic workup since it is the most sensitive test for the detection of disseminated histoplasmosis [<a href="#rid16">16,30,31</a>]. Antigen testing can be performed on urine, serum, bronchoalveolar lavage (BAL) fluid, and cerebrospinal fluid (CSF) [<a href="#rid16">16</a>]. Serum antigen can occasionally be positive when urine results are negative [<a href="#rid30">30,32</a>]. In one report, antigen was detected in patients with advanced HIV and disseminated histoplasmosis in the following samples: urine (97 percent), blood (83 percent), and CSF (67 percent) [<a href="#rid8">8</a>]. In another report, antigen testing was positive in 39 of 40 patients with HIV in urine and 36 of 37 patients in serum [<a href="#rid16">16</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Histopathology</strong> − If tissue samples are available (eg, bone marrow or lymph node biopsy, mucocutaneous lesions), we perform periodic acid-Schiff or methenamine silver stains to evaluate for <em>H. capsulatum</em>. Laboratory evidence of granulomas with yeasts resembling <em>Histoplasma</em> <em>spp</em> in extrapulmonary tissues is consistent with disseminated disease  (<a class="graphic graphic_picture graphicRef75209 graphicRef74406 graphicRef65482" href="/d/graphic/75209.html" rel="external">picture 3A-C</a>) [<a href="#rid33">33</a>]. However, histopathologic examination of tissues using special stains requires additional facilities and a pathologist, tissue preparation can lead to a delay in diagnosis, and sensitivity is low.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Direct microscopy</strong> − Direct microscopy can be performed on a routine peripheral blood smear or a buffy coat preparation, as well as on other body fluids, such as bone marrow or lymph node aspirates. Visualization of the organism within macrophages on a Wright-stained peripheral blood smear allows for inexpensive and rapid identification and diagnosis of histoplasmosis, although the sensitivity is low (less than 10 percent) [<a href="#rid16">16,34</a>]. Bone marrow and lymph node aspirates can be stained with Wright, Giemsa, or May-Grünwald-Giemsa stains [<a href="#rid35">35</a>]. Visualization of budding yeast 2 to 4 micrometers in a body fluid is diagnostic of histoplasmosis; <em>Histoplasma </em>yeasts can occasionally be confused with <em>Candida glabrata</em>, <em>Talaromyces marneffei</em>, and amastigote forms of <em>Leishmania</em> [<a href="#rid25">25</a>].</p><p></p><p class="bulletIndent1">Combining culture with direct microscopy increases the diagnostic yield. In a study of 36 persons with advanced HIV and suspected disseminated disease, the combination of blood culture plus examination of the peripheral smear by direct microscopy had a sensitivity of 88 percent for diagnosis [<a href="#rid34">34</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Culture</strong> − Culture of blood, respiratory samples, or other tissues (eg, bone marrow) remains the "gold standard" for diagnosis  (<a class="graphic graphic_picture graphicRef68444" href="/d/graphic/68444.html" rel="external">picture 1</a>); however, cultures of <em>H. capsulatum</em> may take up to four to six weeks to grow and sensitivity depends on disease burden and type of specimen [<a href="#rid25">25</a>]. In one retrospective study of 46 patients with advanced HIV and disseminated disease, blood cultures using the lysis-centrifugation system were positive in 50 percent of patients [<a href="#rid16">16</a>]. In a study of 184 Colombian patients with HIV and histoplasmosis, 59 (32 percent) had positive tissue cultures, 22 (12 percent) had positive BAL cultures, 14 (7.6 percent) had positive skin scrapings cultures, 11 (6 percent) had positive sputum cultures, and 8 (4.3 percent) had positive whole blood cultures [<a href="#rid36">36</a>]. The reported diagnostic yield of BAL in patients with advanced HIV has varied, but one small study of 27 patients found the sensitivity of stain and culture using BAL fluid to be 70 percent and 89 percent, respectively [<a href="#rid37">37</a>]. The diagnostic yield of sputum in patients with advanced HIV has not been well studied. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Serology</strong> − Serologic tests are of limited value in the initial diagnosis of histoplasmosis since results may be delayed for up to two weeks. Standard serology, consisting of complement fixation and immunodiffusion tests, has a combined diagnostic yield of approximately 70 to 92 percent in patients with advanced HIV and histoplasmosis [<a href="#rid30">30,36</a>], although nonreactive serologic testing has also been described [<a href="#rid8">8,36</a>]. Immunodiffusion is less sensitive but more specific than complement fixation [<a href="#rid36">36,38</a>].</p><p></p><p class="headingAnchor" id="H4280967039"><span class="h2">Postdiagnostic evaluation</span><span class="headingEndMark"> — </span>Once diagnosis is made either by culture, pathology, or antigen testing results, patients who report neurologic symptoms (eg, headache, paresthesias) or demonstrate neurologic deficits on exam should be evaluated for CNS disease with brain magnetic resonance imaging and a lumbar puncture. If meningitis is present, CSF results reflect fungal meningitis. </p><p>Patients who did not have a <em>Histoplasma</em> urine antigen test sent prior to diagnosis should have one sent after the diagnosis is made, as it will be helpful to monitor response to therapy over time. (See  <a class="medical medical_review" href="/d/html/6996.html" rel="external">"Treatment of histoplasmosis in patients with HIV", section on 'Monitoring of patients'</a>.) </p><p class="headingAnchor" id="H2028756157"><span class="h2">Evaluation for concurrent infections</span><span class="headingEndMark"> — </span>As part of the diagnostic evaluation, we conduct a careful search for coinfections since patients with advanced HIV may be concurrently infected with multiple opportunistic pathogens. Common concurrent infections include typical bacterial pneumonia, tuberculosis, disseminated mycobacterium avium complex, pneumocystis pneumonia, and cryptococcal pneumonia or meningitis. (See  <a class="medical medical_review" href="/d/html/3747.html" rel="external">"Overview of prevention of opportunistic infections in patients with HIV"</a>.) </p><p class="headingAnchor" id="H593669002"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/d/html/111612.html" rel="external">"Society guideline links: Opportunistic infections in adults with HIV"</a> and  <a class="medical medical_society_guidelines" href="/d/html/120865.html" rel="external">"Society guideline links: Histoplasmosis"</a>.)</p><p class="headingAnchor" id="H7985700"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/87577.html" rel="external">"Patient education: Histoplasmosis (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H8"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology</strong> − Histoplasmosis is the most common endemic mycosis in patients with advanced HIV, although the risk of disease has declined with effective antiretroviral therapy. A CD4 count ≤150 cells/microL is the main risk factor for histoplasmosis in patients with HIV. (See <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Transmission</strong> − Transmission of <em>Histoplasma</em> occurs via inhalation of spores from the soil of endemic areas (eg, Mississippi and Ohio river valleys in the United States, the Caribbean, southern Mexico, certain parts of Central and South America, Africa, and Asia), which can lead to acute infection; some patients also develop disease many years after travel to an endemic area due to reactivation of latent foci. (See <a class="local">'Epidemiology'</a> above and <a class="local">'Microbiology and pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Spectrum of disease</strong> − Histoplasmosis can range from asymptomatic infection to life-threatening disseminated disease. Isolated pulmonary involvement without dissemination in patients with advanced HIV is rare. (See <a class="local">'Spectrum and time course of disease'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Disseminated disease</strong> − Patients with advanced HIV (CD4 count ≤150 cells/microL) usually develop acute disseminated histoplasmosis, characterized by fever, night sweats, weight loss, hepatosplenomegaly, elevated alkaline phosphatase and transaminases, and pancytopenia. Pulmonary infiltrates (eg, diffuse interstitial or reticulonodular infiltrates) are seen in 40 to 50 percent of patients with advanced HIV and disseminated histoplasmosis  (<a class="graphic graphic_diagnosticimage graphicRef79439" href="/d/graphic/79439.html" rel="external">image 1</a>). (See <a class="local">'Clinical signs and symptoms'</a> above and <a class="local">'Laboratory abnormalities'</a> above and <a class="local">'Radiographic manifestations'</a> above.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>When to suspect histoplasmosis in patients with HIV</strong></p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Disseminated histoplasmosis should be suspected in patients with HIV and CD4 counts ≤150 cells/microL who are from and/or living in a histoplasmosis-endemic area and present with clinical manifestations consistent with disseminated histoplasmosis, such as: </p><p></p><p class="bulletIndent3"><span class="glyph">-</span>Fevers and weight loss</p><p class="bulletIndent3"><span class="glyph">-</span>Cough and/or dyspnea</p><p class="bulletIndent3"><span class="glyph">-</span>Skin and/or mucosal membrane lesions  (<a class="graphic graphic_picture graphicRef78902" href="/d/graphic/78902.html" rel="external">picture 2</a>)</p><p class="bulletIndent3"><span class="glyph">-</span>Nausea, vomiting, and abdominal pain</p><p class="bulletIndent3"><span class="glyph">-</span>Hepatosplenomegaly and/or lymphadenopathy</p><p class="bulletIndent3"><span class="glyph">-</span>Pancytopenia</p><p class="bulletIndent3"><span class="glyph">-</span>Other symptoms depending on organ system involved (see <a class="local">'When to suspect histoplasmosis'</a> above)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Approach to diagnosis</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients in whom disseminated histoplasmosis is suspected, we send serum and urine <em>Histoplasma </em>antigen, and fungal blood cultures. Examination of tissues or body fluids for fungi using special stains (eg, Giemsa stain for bone marrow aspirates, methenamine silver stain  (<a class="graphic graphic_picture graphicRef65482" href="/d/graphic/65482.html" rel="external">picture 3C</a>) for tissue specimens) and culture of any available tissue or fluid specimens (eg, bone marrow aspirate, lymph node aspirate, skin biopsy tissue) should be performed  (<a class="graphic graphic_picture graphicRef68444" href="/d/graphic/68444.html" rel="external">picture 1</a>). Laboratory evidence of granulomas with yeasts resembling <em>Histoplasma </em>in extrapulmonary tissues is consistent with disseminated disease  (<a class="graphic graphic_picture graphicRef75209 graphicRef74406 graphicRef65482" href="/d/graphic/75209.html" rel="external">picture 3A-C</a>). (See <a class="local">'Approach to diagnosis'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Other diagnostic tests include direct microscopy of a peripheral blood smear, bone marrow aspirate, or lymph node aspirate, and serology. Sensitivity of these tests is low. (See <a class="local">'Approach to diagnosis'</a> above.) </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Identification of <em>H. capsulatum</em> by staining or culture confirms the diagnosis. A positive antigen test strongly supports the diagnosis. (See <a class="local">'Approach to diagnosis'</a> above.)</p><p></p><p class="headingAnchor" id="H1679155696"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>UpToDate gratefully acknowledges John G Bartlett, MD (deceased), who contributed as Section Editor on earlier versions of this topic and was a founding Editor-in-Chief for UpToDate in Infectious Diseases.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Wheat LJ, Chetchotisakd P, Williams B, et al. Factors associated with severe manifestations of histoplasmosis in AIDS. Clin Infect Dis 2000; 30:877.</a></li><li><a class="nounderline abstract_t">Hage CA, Wheat LJ, Loyd J, et al. Pulmonary histoplasmosis. Semin Respir Crit Care Med 2008; 29:151.</a></li><li><a class="nounderline abstract_t">Putot A, Perrin S, Jolivet A, Vantilcke V. HIV-associated disseminated histoplasmosis in western French Guiana, 2002-2012. Mycoses 2015; 58:160.</a></li><li><a class="nounderline abstract_t">Hajjeh RA, Pappas PG, Henderson H, et al. Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons. Clin Infect Dis 2001; 32:1215.</a></li><li><a class="nounderline abstract_t">de Oliveira RB, Atobe JH, Souza SA, de Castro Lima Santos DW. Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil. Mycopathologia 2014; 178:71.</a></li><li><a class="nounderline abstract_t">Mora DJ, dos Santos CT, Silva-Vergara ML. Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil. Mycoses 2008; 51:136.</a></li><li><a class="nounderline abstract_t">Murray JF, Mills J. Pulmonary infectious complications of human immunodeficiency virus infection. Part II. Am Rev Respir Dis 1990; 141:1582.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Connolly-Stringfield PA, Baker RL, et al. Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature. Medicine (Baltimore) 1990; 69:361.</a></li><li><a class="nounderline abstract_t">Hajjeh RA. Disseminated histoplasmosis in persons infected with human immunodeficiency virus. Clin Infect Dis 1995; 21 Suppl 1:S108.</a></li><li><a class="nounderline abstract_t">Benedict K, McCracken S, Signs K, et al. Enhanced Surveillance for Histoplasmosis-9 States, 2018-2019. Open Forum Infect Dis 2020; 7:ofaa343.</a></li><li><a class="nounderline abstract_t">Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature. Medicine (Baltimore) 2006; 85:22.</a></li><li><a class="nounderline abstract_t">Bahr NC, Antinori S, Wheat LJ, Sarosi GA. Histoplasmosis infections worldwide: thinking outside of the Ohio River valley. Curr Trop Med Rep 2015; 2:70.</a></li><li><a class="nounderline abstract_t">Benedict K, Thompson GR 3rd, Deresinski S, Chiller T. Mycotic Infections Acquired outside Areas of Known Endemicity, United States. Emerg Infect Dis 2015; 21:1935.</a></li><li><a class="nounderline abstract_t">Vail GM, Mocherla S, Wheat LJ, et al. Cellular immune response in HIV-infected patients with histoplasmosis. J Acquir Immune Defic Syndr 2002; 29:49.</a></li><li><a class="nounderline abstract_t">Myint T, Leedy N, Villacorta Cari E, Wheat LJ. HIV-Associated Histoplasmosis: Current Perspectives. HIV AIDS (Auckl) 2020; 12:113.</a></li><li><a class="nounderline abstract_t">Baddley JW, Sankara IR, Rodriquez JM, et al. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis 2008; 62:151.</a></li><li><a class="nounderline abstract_t">Shelburne SA 3rd, Visnegarwala F, Adams C, et al. Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy. Am J Med 2005; 118:1038.</a></li><li><a class="nounderline abstract_t">Develoux M, Amona FM, Hennequin C. Histoplasmosis Caused by Histoplasma capsulatum var. duboisii: A Comprehensive Review of Cases From 1993 to 2019. Clin Infect Dis 2021; 73:e543.</a></li><li><a class="nounderline abstract_t">Sarosi GA, Johnson PC. Disseminated histoplasmosis in patients infected with human immunodeficiency virus. Clin Infect Dis 1992; 14 Suppl 1:S60.</a></li><li><a class="nounderline abstract_t">Johnson PC, Khardori N, Najjar AF, et al. Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome. Am J Med 1988; 85:152.</a></li><li><a class="nounderline abstract_t">Adenis A, Nacher M, Hanf M, et al. HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority. PLoS Negl Trop Dis 2014; 8:e3100.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Slama TG, Zeckel ML. Histoplasmosis in the acquired immune deficiency syndrome. Am J Med 1985; 78:203.</a></li><li class="breakAll">Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available at http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. (Accessed on June 23, 2020).</li><li><a class="nounderline abstract_t">Karimi K, Wheat LJ, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil. J Infect Dis 2002; 186:1655.</a></li><li><a class="nounderline abstract_t">Couppié P, Aznar C, Carme B, Nacher M. American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis. Curr Opin Infect Dis 2006; 19:443.</a></li><li><a class="nounderline abstract_t">Melzani A, de Reynal de Saint Michel R, Ntab B, et al. Incidence and Trends in Immune Reconstitution Inflammatory Syndrome Associated With Histoplasma capsulatum Among People Living With Human Immunodeficiency Virus: A 20-Year Case Series and Literature Review. Clin Infect Dis 2020; 70:643.</a></li><li><a class="nounderline abstract_t">Agudelo CA, Restrepo CA, Molina DA, et al. Tuberculosis and histoplasmosis co-infection in AIDS patients. Am J Trop Med Hyg 2012; 87:1094.</a></li><li class="breakAll">Pan American Health Organization and World Health Organization. Guidelines for Diagnosing and Managing Disseminated Histoplasmosis among People Living with HIV. https://iris.paho.org/handle/10665.2/52304 (Accessed on June 26, 2023).</li><li><a class="nounderline abstract_t">Donnelly JP, Chen SC, Kauffman CA, et al. Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium. Clin Infect Dis 2020; 71:1367.</a></li><li><a class="nounderline abstract_t">Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis 2011; 53:448.</a></li><li><a class="nounderline abstract_t">Caceres DH, Knuth M, Derado G, Lindsley MD. Diagnosis of Progressive Disseminated Histoplasmosis in Advanced HIV: A Meta-Analysis of Assay Analytical Performance. J Fungi (Basel) 2019; 5.</a></li><li><a class="nounderline abstract_t">Connolly PA, Durkin MM, Lemonte AM, et al. Detection of histoplasma antigen by a quantitative enzyme immunoassay. Clin Vaccine Immunol 2007; 14:1587.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45:807.</a></li><li><a class="nounderline abstract_t">Nightingale SD, Parks JM, Pounders SM, et al. Disseminated histoplasmosis in patients with AIDS. South Med J 1990; 83:624.</a></li><li><a class="nounderline abstract_t">Akpek G, Lee SM, Gagnon DR, et al. Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections. Am J Hematol 2001; 67:100.</a></li><li><a class="nounderline abstract_t">Arango-Bustamante K, Restrepo A, Cano LE, et al. Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients. Am J Trop Med Hyg 2013; 89:937.</a></li><li><a class="nounderline abstract_t">Prechter GC, Prakash UB. Bronchoscopy in the diagnosis of pulmonary histoplasmosis. Chest 1989; 95:1033.</a></li><li><a class="nounderline abstract_t">Wheat LJ, Connolly-Stringfield P, Blair R, et al. Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels. Ann Intern Med 1991; 115:936.</a></li></ol></div><div id="topicVersionRevision">Topic 6991 Version 31.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10854363" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Factors associated with severe manifestations of histoplasmosis in AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18365997" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Pulmonary histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25641000" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : HIV-associated disseminated histoplasmosis in western French Guiana, 2002-2012.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11283812" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Multicenter case-control study of risk factors for histoplasmosis in human immunodeficiency virus-infected persons.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24952013" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Epidemiology of invasive fungal infections in patients with acquired immunodeficiency syndrome at a reference hospital for infectious diseases in Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18254750" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Disseminated histoplasmosis in acquired immunodeficiency syndrome patients in Uberaba, MG, Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2190509" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Pulmonary infectious complications of human immunodeficiency virus infection. Part II.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2233233" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Disseminated histoplasmosis in the acquired immune deficiency syndrome: clinical findings, diagnosis and treatment, and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8547497" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Disseminated histoplasmosis in persons infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32964064" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Enhanced Surveillance for Histoplasmosis-9 States, 2018-2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16523050" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Histoplasmosis among human immunodeficiency virus-infected people in Europe: report of 4 cases and review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26279969" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Histoplasmosis infections worldwide: thinking outside of the Ohio River valley.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26485441" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Mycotic Infections Acquired outside Areas of Known Endemicity, United States.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11782589" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Cellular immune response in HIV-infected patients with histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32256121" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : HIV-Associated Histoplasmosis: Current Perspectives.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18597967" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16164892" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Unusual manifestations of disseminated Histoplasmosis in patients responding to antiretroviral therapy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32887981" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Histoplasmosis Caused by Histoplasma capsulatum var. duboisii: A Comprehensive Review of Cases From 1993 to 2019.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1562697" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Disseminated histoplasmosis in patients infected with human immunodeficiency virus.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3400691" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Progressive disseminated histoplasmosis in patients with acquired immunodeficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25144374" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : HIV-associated histoplasmosis early mortality and incidence trends: from neglect to priority.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3871588" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Histoplasmosis in the acquired immune deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3871588" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Histoplasmosis in the acquired immune deficiency syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12447743" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in the United States and Brazil.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16940867" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : American histoplasmosis in developing countries with a special focus on patients with HIV: diagnosis, treatment, and prognosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30921453" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Incidence and Trends in Immune Reconstitution Inflammatory Syndrome Associated With Histoplasma capsulatum Among People Living With Human Immunodeficiency Virus: A 20-Year Case Series and Literature Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23128292" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Tuberculosis and histoplasmosis co-infection in AIDS patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23128292" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Tuberculosis and histoplasmosis co-infection in AIDS patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31802125" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21810734" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : A multicenter evaluation of tests for diagnosis of histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31426618" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Diagnosis of Progressive Disseminated Histoplasmosis in Advanced HIV: A Meta-Analysis of Assay Analytical Performance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17913863" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Detection of histoplasma antigen by a quantitative enzyme immunoassay.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17806045" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2356493" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Disseminated histoplasmosis in patients with AIDS.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11343381" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Bone marrow aspiration, biopsy, and culture in the evaluation of HIV-infected patients for invasive mycobacteria and histoplasma infections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24043688" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Diagnostic value of culture and serological tests in the diagnosis of histoplasmosis in HIV and non-HIV Colombian patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2707059" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Bronchoscopy in the diagnosis of pulmonary histoplasmosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1952490" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Histoplasmosis relapse in patients with AIDS: detection using Histoplasma capsulatum variety capsulatum antigen levels.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
